AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19930864 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation, adequate knowledge and skills, record keeping (actions that can be changed by GPs themselves)
Number of subjects: 0
Study 19930864 — intervention group
Group type: EXPERIMENTAL
Intervention: Community action (government intervention)
Number of subjects: 0
Study 16862472 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of intravenous cephalothin 2 g, intraoperatively
Number of subjects: 600
Study 16862472 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard antibiotics scheme followed at this center (penicillin)
Number of subjects: 600
Study 16862472 — intervention group
Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 600
Study 14660044 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult mesenchymal stem cells (MSC)
Number of subjects: 0
Study 14660044 — intervention group
Group type: EXPERIMENTAL
Intervention: First trimester fetal MSC
Number of subjects: 0
Study 10858827 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucin-based artificial saliva (Saliva Orthana)
Number of subjects: 0
Study 10858827 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-tack, sugar-free chewing gum (Freedent)
Number of subjects: 0
Study 10858827 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 9009151 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch therapy (group Q)
Number of subjects: 50
Study 9009151 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch therapy (group R)
Number of subjects: 50
Study 9009151 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch (control group)
Number of subjects: 50
Study 8251901 — intervention group
Group type: EXPERIMENTAL
Intervention: Splenic irradiation (SI+)
Number of subjects: 229
Study 8251901 — intervention group
Group type: COMPARATOR
Intervention: No splenic irradiation (SI-)
Number of subjects: 229
Study 8251901 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SI+ and SI-)
Number of subjects: 229
Study 2871185 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol consumption prior to cognitive task
Number of subjects: 20
Study 2871185 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol consumption prior to electronic game
Number of subjects: 20
Study 2871185 — intervention group
Group type: COMPARATOR
Intervention: No ethanol consumption (control)
Number of subjects: 20
Study 30445895 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotics
Number of subjects: 175
Study 30445895 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiolytics
Number of subjects: 175
Study 30445895 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher antipsychotic dosage at discharge
Number of subjects: 175
Study 26840944 — intervention group
Group type: EXPERIMENTAL
Intervention: Billroth I reconstruction
Number of subjects: 122
Study 26840944 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y reconstruction
Number of subjects: 122
Study 24885735 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-minute rope skipping activity inserted in four consecutive PE lessons
Number of subjects: 24
Study 24885735 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 24
Study 22016263 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied tension during the pre‐donation wait period
Number of subjects: 282
Study 22016263 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied tension during the blood draw
Number of subjects: 282
Study 22016263 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied tension during both pre‐donation wait period and blood draw
Number of subjects: 282
Study 22016263 — intervention group
Group type: COMPARATOR
Intervention: No applied tension at all (control group)
Number of subjects: 282
Study 20347286 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional exercise therapy (TET) program
Number of subjects: 176
Study 20347286 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral lifestyle activity program (LAP)
Number of subjects: 176
Study 18360186 — intervention group
Group type: EXPERIMENTAL
Intervention: Modular group (n = 72)
Number of subjects: 144
Study 18360186 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 72)
Number of subjects: 144
Study 15814481 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated Portland Digit Recognition Test (PDRT)
Number of subjects: 200
Study 15814481 — intervention group
Group type: COMPARATOR
Intervention: Standard Portland Digit Recognition Test (PDRT)
Number of subjects: 200
Study 11919489 — intervention group
Group type: EXPERIMENTAL
Intervention: MSL-109
Number of subjects: 83
Study 11919489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 10342080 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate alone (50 mg/m2 intramuscularly)
Number of subjects: 358
Study 10342080 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate followed by misoprostol (800 micrograms vaginally)
Number of subjects: 358
Study 10342080 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 358
Study 8620703 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone, 50 mg (PRED)
Number of subjects: 10
Study 8620703 — intervention group
Group type: COMPARATOR
Intervention: Inhaled placebo (PL)
Number of subjects: 10
Study 8620703 — intervention group
Group type: COMPARATOR
Intervention: Inhaled fluticasone propionate, 1,000 micrograms (F1000)
Number of subjects: 10
Study 8620703 — intervention group
Group type: COMPARATOR
Intervention: Inhaled fluticasone propionate, 2,000 micrograms (F2000)
Number of subjects: 10
Study 1835830 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride solution
Number of subjects: 77
Study 1835830 — intervention group
Group type: COMPARATOR
Intervention: Dilute heparin solution
Number of subjects: 77
Study 7343723 — intervention group
Group type: EXPERIMENTAL
Intervention: guanethidine/epinephrine combination
Number of subjects: 50
Study 7343723 — intervention group
Group type: COMPARATOR
Intervention: timolol maleate/epinephrine
Number of subjects: 50
Study 31526108 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Number of subjects: 13
Study 31526108 — intervention group
Group type: COMPARATOR
Intervention: Normal Sleep (NS)
Number of subjects: 13
Study 28463672 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation of the inferior mesenteric artery distal to the left colic artery (low ligation)
Number of subjects: 66
Study 28463672 — intervention group
Group type: COMPARATOR
Intervention: Complete preservation of the inferior mesenteric artery (IMA preservation)
Number of subjects: 66
Study 26359076 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral block (CFNB)
Number of subjects: 280
Study 26359076 — intervention group
Group type: COMPARATOR
Intervention: Patient controlled intravenous analgesia (PCIA)
Number of subjects: 280
Study 23426616 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (100 mg/kg/d for 4 weeks)
Number of subjects: 4
Study 23426616 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects (11 untrained, age- and sex-matched)
Number of subjects: 4
Study 21163806 — intervention group
Group type: EXPERIMENTAL
Intervention: Piecewise linear approach to model smoking and gene-by-smoking interactions
Number of subjects: 0
Study 21163806 — intervention group
Group type: COMPARATOR
Intervention: Total pack-years approach
Number of subjects: 0
Study 19276620 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids
Number of subjects: 72
Study 19276620 — intervention group
Group type: EXPERIMENTAL
Intervention: antioxidants
Number of subjects: 72
Study 19276620 — intervention group
Group type: EXPERIMENTAL
Intervention: both supplements (antioxidants and n-3 fatty acids)
Number of subjects: 72
Study 19276620 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study 17327261 — intervention group
Group type: EXPERIMENTAL
Intervention: loveLife national HIV prevention programme
Number of subjects: 0
Study 15310346 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol sedation
Number of subjects: 0
Study 15310346 — intervention group
Group type: COMPARATOR
Intervention: Midazolam sedation
Number of subjects: 0
Study 11782332 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural sufentanil with epinephrine (100 microg/mL)
Number of subjects: 43
Study 11782332 — intervention group
Group type: COMPARATOR
Intervention: Epidural sufentanil without epinephrine (saline)
Number of subjects: 43
Study 9821033 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 1314
Study 9821033 — intervention group
Group type: COMPARATOR
Intervention: Prior contralateral stroke
Number of subjects: 1314
Study 9821033 — intervention group
Group type: COMPARATOR
Intervention: Prior TIA
Number of subjects: 1314
Study 9821033 — intervention group
Group type: COMPARATOR
Intervention: Prior amaurosis fugax
Number of subjects: 1314
Study 9821033 — intervention group
Group type: COMPARATOR
Intervention: No prior symptoms
Number of subjects: 1314
Study 7703623 — intervention group
Group type: EXPERIMENTAL
Intervention: MFP-calcium-treated group (sodium monofluorophosphate 26 mg/day of fluoride + 1000 mg of calcium)
Number of subjects: 48
Study 7703623 — intervention group
Group type: COMPARATOR
Intervention: Control group (calcium alone)
Number of subjects: 48
Study 2667315 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw manihot starch
Number of subjects: 18
Study 2667315 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked starches
Number of subjects: 18
Study 2667315 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooked mung bean noodles
Number of subjects: 18
Study 2667315 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro starch hydrolysis at 30 min
Number of subjects: 18
Study 1064725 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygel application and tooth brushing twice a day
Number of subjects: 0
Study 1064725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31392401 — intervention group
Group type: EXPERIMENTAL
Intervention: 28.2-μg twice-weekly teriparatide
Number of subjects: 553
Study 31392401 — intervention group
Group type: COMPARATOR
Intervention: 56.5-μg once-weekly teriparatide
Number of subjects: 553
Study 28290296 — intervention group
Group type: EXPERIMENTAL
Intervention: Sourdough breads made with organic flour
Number of subjects: 16
Study 28290296 — intervention group
Group type: EXPERIMENTAL
Intervention: Sourdough breads made with einkorn flour
Number of subjects: 16
Study 28290296 — intervention group
Group type: EXPERIMENTAL
Intervention: All sourdough breads
Number of subjects: 16
Study 28290296 — intervention group
Group type: EXPERIMENTAL
Intervention: Einkorn bread
Number of subjects: 16
Study 25482330 — intervention group
Group type: EXPERIMENTAL
Intervention: Simeprevir (150 mg once a day) plus peginterferon alfa‐2a and ribavirin
Number of subjects: 763
Study 25482330 — intervention group
Group type: COMPARATOR
Intervention: Telaprevir (750 mg three times a day) plus peginterferon alfa‐2a and ribavirin
Number of subjects: 763
Study 25482330 — intervention group
Group type: EXPERIMENTAL
Intervention: Simeprevir
Number of subjects: 763
Study 25482330 — intervention group
Group type: COMPARATOR
Intervention: Telaprevir
Number of subjects: 763
Study 23507683 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D supplementation
Number of subjects: 4
Study 23507683 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D supplementation
Number of subjects: 4
Study 23507683 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 IU vitamin D supplementation
Number of subjects: 4
Study 23507683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 21689848 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural change, moderate intensity physical activity intervention (n=16)
Number of subjects: 33
Study 21689848 — intervention group
Group type: COMPARATOR
Intervention: Contact Control group (n=17)
Number of subjects: 33
Study 20137594 — intervention group
Group type: EXPERIMENTAL
Intervention: Xue Bijing injection, 100 ml intravenous once a day for 7 days
Number of subjects: 52
Study 20137594 — intervention group
Group type: COMPARATOR
Intervention: Normal saline as placebo
Number of subjects: 52
Study 20137594 — intervention group
Group type: EXPERIMENTAL
Intervention: Xue Bijing injection
Number of subjects: 52
Study 16960242 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed-of-processing intervention
Number of subjects: 2147
Study 16960242 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory intervention
Number of subjects: 2147
Study 16960242 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasoning intervention
Number of subjects: 2147
Study 16960242 — intervention group
Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 2147
Study 15228371 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred biologic therapy recommended for prior-authorization (PA) criteria
Number of subjects: 0
Study 15228371 — intervention group
Group type: COMPARATOR
Intervention: Biologic agent with marginal incremental clinical benefit
Number of subjects: 0
Study 15228371 — intervention group
Group type: EXPERIMENTAL
Intervention: Biologic agent with increased efficacy
Number of subjects: 0
Study 15228371 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible PA criteria for drug coverage
Number of subjects: 0
Study 11703235 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine with Hartmann's solution
Number of subjects: 56
Study 11703235 — intervention group
Group type: COMPARATOR
Intervention: Control group (Hartmann's solution without bupivacaine)
Number of subjects: 56
Study 9130221 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% mepivicaine (1.0 ml)
Number of subjects: 44
Study 9130221 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 44
Study 8190448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam (3 g every 6 hours)
Number of subjects: 415
Study 8190448 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin (2 g every 6 hours) plus doxycycline (100 mg every 12 hours)
Number of subjects: 415
Study 8190448 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin (900 mg every 8 hours) plus gentamicin (1.5 mg/kg every 8 hours)
Number of subjects: 415
Study 8190448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin-sulbactam
Number of subjects: 415
Study 8190448 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin plus doxycycline
Number of subjects: 415
Study 8190448 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin plus gentamicin
Number of subjects: 415
Study 3370078 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam 1600 mg
Number of subjects: 9
Study 3370078 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam 2400 mg
Number of subjects: 9
Study 3370078 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31782495 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge about dengue and its severity
Number of subjects: 330
Study 31782495 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of types of mosquitoes causing dengue
Number of subjects: 330
Study 31782495 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with willingness to pay (WTP) for mosquito control
Number of subjects: 330
Study 30460634 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Azacytidine (5-AZA) 10 mg infusions, 12 consecutive weekly infusions planned
Number of subjects: 6
Study 27858681 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manual therapy (OMT) and exercise methods
Number of subjects: 39
Study 27858681 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral osteopathic manual therapy (vOMT)
Number of subjects: 39
Study 25977995 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord blood (UCB)
Number of subjects: 36
Study 25977995 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 23908160 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% crude glycerin
Number of subjects: 240
Study 23908160 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% crude glycerin
Number of subjects: 240
Study 23908160 — intervention group
Group type: COMPARATOR
Intervention: 0% crude glycerin (control)
Number of subjects: 240
Study 23908160 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude glycerin (0, 2.5, 5%)
Number of subjects: 240
Study 22188876 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored training in applying the guidelines for depression (Intervention Group, n = 21)
Number of subjects: 40
Study 22188876 — intervention group
Group type: COMPARATOR
Intervention: Alternative programme (Control Group, n = 19)
Number of subjects: 40
Study 17909808 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg granular formulation of gefitinib
Number of subjects: 18
Study 17909808 — intervention group
Group type: COMPARATOR
Intervention: 250 mg tablet of gefitinib
Number of subjects: 18
Study 16552473 — intervention group
Group type: EXPERIMENTAL
Intervention: nifedipine GITS
Number of subjects: 7665
Study 16552473 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 7665
Study 12806325 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide
Number of subjects: 8
Study 12806325 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% hydrogen peroxide
Number of subjects: 8
Study 12806325 — intervention group
Group type: COMPARATOR
Intervention: Control group (hybrid composites)
Number of subjects: 8
Study 10918945 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium antagonist (benidipine)
Number of subjects: 15
Study 10918945 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin converting enzyme inhibitor (trandolapril)
Number of subjects: 15
Study 10918945 — intervention group
Group type: COMPARATOR
Intervention: Normotensive subjects (control group)
Number of subjects: 15
Study 8855458 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthetic blocks (C2-C3 zygapophysial joint)
Number of subjects: 68
Study 8855458 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled local anesthetic blocks
Number of subjects: 68
Study 8855458 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall prevalence assessment
Number of subjects: 68
Study 1509527 — intervention group
Group type: EXPERIMENTAL
Intervention: Low birth weight formula
Number of subjects: 22
Study 1509527 — intervention group
Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 22
Study 6139191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of hydroxyzine (10 mg qds) and cimetidine (400 mg qds)
Number of subjects: 50
Study 6139191 — intervention group
Group type: COMPARATOR
Intervention: Other antihistamine regimes
Number of subjects: 50
Study 31512201 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM)
Number of subjects: 16007
Study 31512201 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediabetes
Number of subjects: 16007
Study 31512201 — intervention group
Group type: COMPARATOR
Intervention: No Diabetes
Number of subjects: 16007
Study 29449140 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent self-management intervention (MCI)
Number of subjects: 102
Study 29449140 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 102
Study 26618243 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD-CV/dPly/PhtD-30
Number of subjects: 120
Study 26618243 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 120
Study 23627422 — intervention group
Group type: EXPERIMENTAL
Intervention: High mutability induction
Number of subjects: 688
Study 23627422 — intervention group
Group type: COMPARATOR
Intervention: Low mutability induction
Number of subjects: 688
Study 23627422 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on uniqueness of values
Number of subjects: 688
Study 23627422 — intervention group
Group type: COMPARATOR
Intervention: Feedback on similarity of values
Number of subjects: 688
Study 23627422 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback on uniqueness of traits
Number of subjects: 688
Study 23627422 — intervention group
Group type: COMPARATOR
Intervention: Feedback on similarity of traits
Number of subjects: 688
Study 23627422 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported values and traits
Number of subjects: 688
Study 22406278 — intervention group
Group type: EXPERIMENTAL
Intervention: ProQuad(®) (MMRV vaccine) Dose 1 at 9 months
Number of subjects: 0
Study 22406278 — intervention group
Group type: EXPERIMENTAL
Intervention: ProQuad(®) (MMRV vaccine) Dose 1 at 11 months
Number of subjects: 0
Study 22406278 — intervention group
Group type: EXPERIMENTAL
Intervention: ProQuad(®) (MMRV vaccine) Dose 1 at 12 months
Number of subjects: 0
Study 22406278 — intervention group
Group type: EXPERIMENTAL
Intervention: ProQuad(®) (MMRV vaccine) Dose 1 at 9 months, 11 months, or 12 months
Number of subjects: 0
Study 20162300 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast dynamic stretching at 100 b/min (FDS)
Number of subjects: 24
Study 20162300 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow dynamic stretching at 50 b/min (SDS)
Number of subjects: 24
Study 20162300 — intervention group
Group type: COMPARATOR
Intervention: No stretching (NS)
Number of subjects: 24
Study 17916667 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% glucose beverage (1.00 g carbohydrate/kg body mass)
Number of subjects: 15
Study 17916667 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage (NG)
Number of subjects: 15
Study 11731997 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 49
Study 11731997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 9405898 — intervention group
Group type: EXPERIMENTAL
Intervention: Palmitic acid-rich diet
Number of subjects: 15
Study 9405898 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearic acid-rich diet
Number of subjects: 15
Study 9405898 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich diet
Number of subjects: 15
Study 9405898 — intervention group
Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 15
Study 8476333 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance information suggesting sexual content
Number of subjects: 269
Study 8476333 — intervention group
Group type: COMPARATOR
Intervention: Advance information suggesting nonsexual content
Number of subjects: 269